CYNAF Stock UPDATES Cynapsus Therapeutic (CYNAF) 0.5870 09/11/2014

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Cynapsus Therapeutic (CYNAF) 0.5870 $CYNAF

Cynapsus Therapeutics Reports Second Quarter 2014 Financial Results and Recent Developments
Marketwire - Wed Aug 13, 5:01AM CDT
Cynapsus Therapeutics Inc. (TSX VENTURE: CTH)(OTCQX: CYNAF), a specialty pharmaceutical company developing a convenient and easy to use sublingual (oral) thin film strip for the acute rescue of "off" motor symptoms of Parkinson's disease, today announced its results for the three and six months ended June 30, 2014. Unless specified otherwise, all amounts are in Canadian dollars.

Cynapsus Therapeutics Commences Phase 2 Clinical Trials in the United States
Marketwire - Thu Jul 17, 3:16PM CDT
Cynapsus Therapeutics Inc. (TSX VENTURE: CTH)(OTCQX: CYNAF), a specialty pharmaceutical company focused on Parkinson's disease, today announced that following communication from the United States Food and Drug Administration ("the FDA" on July 16, 2014, Phase 2 clinical studies for APL-130277 will commence immediately. Specifically, clinical study CTH-105 will be initiated per the proposal submitted to the FDA under the Company's Investigational New Drug (IND) application. APL-130277 is an easy-to-administer, fast-acting reformulation of apomorphine, which is the only approved drug in the United States, Europe, Japan and other countries, to rescue patients from "off" episodes experienced with Parkinson's disease.

Cynapsus Therapeutics Inc : Cynapsus Therapeutics Commences Phase 2 Clinical Trials in the United States
Thomson Reuters ONE - Thu Jul 17, 3:15PM CDT
July 17 2014

Cynapsus Therapeutics Awarded Second Grant from The Michael J. Fox Foundation for Parkinson's Research
Marketwire - Tue Jul 08, 5:01AM CDT
Cynapsus Therapeutics Inc. (TSX VENTURE: CTH)(OTCQX: CYNAF) today announced that it has been awarded a new grant of US$500,000 from The Michael J. Fox Foundation for Parkinson's Research (MJFF) to support clinical studies to develop APL-130277, a sublingual thin film strip reformulation of apomorphine. This second MJFF grant will be used to fund the Company's CTH-105 clinical study.

Cynapsus Therapeutics Inc. : Cynapsus Therapeutics Awarded Second Grant from The Michael J. Fox Foundation for Parkinson's Research
Thomson Reuters ONE - Tue Jul 08, 12:00AM CDT
July 8, 2014

Cynapsus Announces Interim Summary Results of Human Healthy Volunteer Single 25mg Study for APL-130277
Marketwire - Fri Mar 28, 5:01AM CDT
Cynapsus Therapeutics Inc. (TSX VENTURE: CTH)(OTCQX: CYNAF), a specialty pharmaceutical company, today announced positive interim data from its recently completed healthy volunteer pilot study of a single 25mg sublingual strip (APL-130277) dose of apomorphine. APL-130277 is an easy-to-administer, fast-acting reformulation of apomorphine, which is the only approved drug (in the United States, Europe, Japan and other countries) to rescue patients from "off" episodes. The interim CTH-104 study results indicate that a higher load of drug on the strip does result in a higher amount of drug entering the blood stream.

Cynapsus Therapeutics Inc. : Cynapsus Announces Interim Summary Results of Human Healthy Volunteer Single 25mg Study for APL-130277
Thomson Reuters ONE - Fri Mar 28, 5:00AM CDT
PRESS RELEASE

Cynapsus Therapeutics Reports 2013 Financial Results and Highlights Key Developments
Marketwire - Thu Mar 27, 3:01PM CDT
Cynapsus Therapeutics Inc. (TSX VENTURE: CTH)(OTCQX: CYNAF), a specialty pharmaceutical company developing a convenient and easy to use sublingual (oral) thin film strip for the acute rescue of "off" motor symptoms of Parkinson's disease, today announced its results for the year ended December 31, 2013. Unless specified otherwise, all amounts are in Canadian dollars.

Cynapsus Therapeutics Announces DTC Approval
Marketwire - Thu Feb 27, 8:24AM CST
Cynapsus Therapeutics Inc. ("Cynapsus" or the "Company" (TSX VENTURE: CTH)(OTCQX: CYNAF) today announced that the common shares of the Company (CUSIP 23257Y701) have been made eligible for book-entry delivery and depository services of The Depository Trust Company (the "DTC" to facilitate electronic settlement of transfers of its common shares in the United States.

Cynapsus Therapeutics Appoints Nan Hutchinson to the Board of Directors
Marketwire - Thu Feb 13, 7:02AM CST
Cynapsus Therapeutics Inc. (TSX VENTURE: CTH)(OTCQX: CYNAF), a specialty pharmaceutical company with a lead program in Parkinson's disease, today announced the appointment of Nan Hutchinson to the Board of Directors.

LifeSci Advisors Initiates Coverage of Cynapsus Therapeutics, Inc.
Marketwire - Fri Feb 07, 8:15AM CST
LifeSci Advisors, LLC announcement for Cynapsus Therapeutics, Inc. (TSX VENTURE: CTH) (OTCQX: CYNAF)

Cynapsus Therapeutics Announces Exercise of Warrants
Marketwire - Thu Jan 23, 3:01PM CST
Cynapsus Therapeutics Inc. (TSX VENTURE: CTH)(OTCQX: CYNAF), a specialty pharmaceutical company, today announced that in January, 125,324 warrants with an exercise price of $0.575 have been exercised for total proceeds of $72,062. Following the exercise of these warrants, Cynapsus has 39,009,335 commons shares, 21,426,439 warrants and 2,691,316 options to purchase common shares outstanding.




Scroll down for more posts ▼

Top 10 Most Recent News Articles

Miracle League Marks Two Decades with Big Fundraising Win

Updated Category News Views 58

A Double Decade Celebration of Dream and Dedication The Miracle League of the Triangle sure knows how to throw a party—for them, it's not just a gala; it's a testament to two decades of turning dreams into reality. On October 13th, over 300 guests gathered at the Angus Barn Pavilion in Cary, NC, proving that passion for inclusive baseball is just as alive as it was 20...

Continue Reading
Extra Mile Day: 18 Years of Honoring Unsung Heroes

Updated Category News Views 49

Pedaling for Purpose: A Journey That Sparked a Movement What started as a lone journey across America's roads has turned into a celebrated movement to honor those who often go unnoticed. Back in 2009, Shawn Anderson embarked on an unusual journey. Armed only with a bicycle and determination, he pedaled from San Francisco to Boston—over 4,000 miles in just 90 days. It...

Continue Reading
Fidelis Care Opens $120K Workforce Grants for Aid

Updated Category News Views 112

Fidelis Care Steps Up Workforce Engagement Fidelis Care's latest move introduces a fresh shot at tackling two birds with one stone—economic and health stability for Medicaid members. The Workforce Pathways to Health and Economic Mobility grants present up to $120,000 in support for New Yorkers, an attempt aimed squarely at reducing the vicious cycle that traps many in...

Continue Reading
Nelson Peltz Doubles Down: Burgers or Pucks?

Updated Category News Views 53

Mixing Hockey and Hamburgers: The Peltz Way You'd think a guy like Nelson Peltz wouldn't be juggling hockey sticks and hamburgers at the same time, but here we are. The man, a mogul of sorts with Trian Fund Management, is hopping onto a board seat with a New York hockey company and, oh, by the way, throwing a non-binding $7.35-a-share cash proposal to snatch up Wendy's, a...

Continue Reading
Jamaica's Tourism Rebounds Post-Hurricane Challenges

Updated Category News Views 128

Weathering the Storm: A New Chapter for Jamaica It's been nearly a year since Hurricane Melissa hit, and Jamaica is proving that it won't be pushed around by nature's whims. The island's tourism industry, once battered, is now showing remarkable resilience. With hotels and villas reopening and shaking off the dust, it's safe to say Jamaica is back on its feet, and it's...

Continue Reading
Virginia Cancer Specialists: Leaders in Trusted Cancer Care

Updated Category News Views 42

Decades of Trust in Cancer Care Virginia Cancer Specialists isn't just another name in the sea of healthcare providers. That pride they're feeling? Well, they've got every right to it. Just slapped their physicians' names all over the latest Washingtonian's Top Doctors list for 2026. And this isn’t some under-the-table handshake deal. No, this list is shaped by peer...

Continue Reading
Genefluence Launches Rapid UTI PCR Test at Chelsea Hospital

Updated Category News Views 44

There's a fresh breeze blowing through the dusty corridors of healthcare, shaking things up for the better. You see, Genefluence, the brainchild of Professor Chris Toumazou, isn't just throwing a bunch of tech jargon around—it's setting the stage for a much-needed shake-up in how we handle urinary tract infections (UTIs) and, believe me, it couldn’t have come sooner....

Continue Reading
Unicycive Faces Legal Heat: Shareholder Lawsuit Looms

Updated Category News Views 58

The Unicycive Landslide: What Went Down? Investors, buckle up. Unicycive Therapeutics Inc. (NASDAQ: UNCY) finds itself deep in the muck of a securities class action. Chief honchos, CEO Shalabh Gupta and CFO John Townsend, are taking the heat for allegedly controlling company disclosures that led shareholders to believe in non-existent progress with their third-party...

Continue Reading
Infoya Surges with 665% Growth, Wins Fast 50 Spot

Updated Category News Views 102

From Humble Beginnings to High Achiever Alright, let's touch base on Canada's tech landscape for a moment. Infoya's leap into Deloitte's 2026 Technology Fast 50 isn't just a pat on the back—it's a flashing neon sign of what raw ambition mixed with a pinch of AI can cook up for you. They've banked a whopping 665% revenue growth from 2022 to 2025. Not bad for a company...

Continue Reading
Heritage Wines Meet Non-Alcoholic Trend: New Deal

Updated Category News Views 49

Wine Industry Shifts Gears Well, here's a twist that might just shake up the wine racks. C. Mondavi & Family, from the historic Charles Krug estate, is aligning with Missing Thorn—a name gaining traction in the non-alcoholic wine scene. It’s a move that not only raises eyebrows but could also expand your wine-tasting options come your next sober night out. So what...

Continue Reading

Top 5 Most Recently Viewed Articles

Enhancing Mental Health and Substance Use Services for All

Updated Category News Views 57

The American Institutes for Research (AIR) has launched a hefty initiative aimed at elevating care quality for those on Medicare and Medicaid grappling with serious mental health issues and substance use disorders. This venture solidifies AIR's role in advocating better health outcomes among these vulnerable groups. AIR's Heavy Hit: $73 Million from CMS In a noteworthy...

Continue Reading
SimSpace Welcomes Peter Lee to Board for Cybersecurity Leadership

Updated Category News Views 381

SimSpace Strengthens Leadership with Peter Lee Appointment SimSpace, a leader in the realm of cyber readiness and security optimization, has announced a significant new addition to its Board of Directors: Peter Lee. Recognized for his vast experience in scaling technology companies and a strong background in private equity, Peter's appointment comes at a crucial time as...

Continue Reading
Avocado Oil Market Set for Major Growth in the Coming Years

Updated Category News Views 131

Avocado Oil Market Dynamics and Growth Trends Burlingame, CA – Recent insights reveal that the avocado oil market is on a remarkable growth trajectory. According to comprehensive studies, the market was valued at USD 705.3 million and is set to exceed USD 1,054.2 million by 2032, reflecting a compound annual growth rate (CAGR) of 5.9% during this period. This increase...

Continue Reading
China's Stock Market Revival Sparks Economic Optimism and Growth

Updated Category News Views 186

China’s stock market saw its biggest jump since 2008 when the government rolled out a hefty $114 billion in stimulus. Traders were buzzing about interest rate cuts too, hinting at a genuine attempt to kickstart economic momentum. But let’s not kid ourselves—this is no magic bullet. The backdrop of geopolitical tensions and an ongoing property crisis loomed large...

Continue Reading
Venture Global, Inc. Investors: Join the Class Action Today

Updated Category News Views 209

Venture Global, Inc. Class Action Update Venture Global, Inc. has recently come into the spotlight as a result of a securities class action lawsuit filed on behalf of its investors. This lawsuit, initiated in the Southern District of New York, claims that the company made several misleading statements regarding its initial public offering (IPO) documents. Investors who...

Continue Reading